LifeStance Health Group (NASDAQ:LFST) Director Robert Bessler Sells 75,000 Shares

LifeStance Health Group, Inc. (NASDAQ:LFST) Director Robert Bessler sold 75,000 shares of the company’s stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $8.55, for a total value of $641,250.00. Following the transaction, the director directly owned 1,236,948 shares in the company, valued at $10,575,905.40. The trade was a 5.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Robert Bessler also recently made the following trade(s):

• On Friday, April 24th, Robert Bessler sold 62,147 shares of LifeStance Health Group stock. The stock was sold at an average price of $7.05, for a total value of $438,136.35.
• On Thursday, April 23rd, Robert Bessler sold 7,752 shares of LifeStance Health Group stock. The shares were sold at an average price of $7.00, for a total value of $54,264.00.
• On Tuesday, April 21st, Robert Bessler sold 5,101 shares of LifeStance Health Group stock. The shares were sold at an average price of $7.01, for a total value of $35,758.01.

LifeStance Health Group Stock Down 0.4%

NASDAQ LFST traded down $0.03 on Monday, reaching $7.67. The company had a trading volume of 12,999,184 shares, compared to its average volume of 3,170,368. The stock has a market capitalization of $2.97 billion, a P/E ratio of 127.83 and a beta of 1.20. The company’s fifty day moving average is $6.80 and its 200 day moving average is $6.68. LifeStance Health Group, Inc. has a 52-week low of $3.74 and a 52-week high of $8.89. The company has a quick ratio of 1.65, a current ratio of 1.65 and a debt-to-equity ratio of 0.17.

LifeStance Health Group (NASDAQ:LFST) last released its quarterly earnings results on Thursday, May 7th. The company reported $0.04 EPS for the quarter, beating analysts’ consensus estimates of $0.01 by $0.03. The business had revenue of $403.48 million during the quarter, compared to analyst estimates of $387.46 million. LifeStance Health Group had a return on equity of 1.55% and a net margin of 1.55%.LifeStance Health Group’s revenue was up 21.2% compared to the same quarter last year. Sell-side analysts anticipate that LifeStance Health Group, Inc. will post 0.08 earnings per share for the current fiscal year.

LifeStance Health Group announced that its Board of Directors has initiated a stock repurchase plan on Wednesday, February 25th that allows the company to buyback $100.00 million in shares. This buyback authorization allows the company to purchase up to 3.6% of its shares through open market purchases. Shares buyback plans are often an indication that the company’s board of directors believes its stock is undervalued.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on LFST shares. KeyCorp raised their target price on LifeStance Health Group from $8.00 to $9.00 and gave the company an “overweight” rating in a research report on Thursday, February 26th. Wall Street Zen raised LifeStance Health Group from a “hold” rating to a “buy” rating in a research report on Sunday, February 8th. Barclays raised their target price on LifeStance Health Group from $8.00 to $9.00 and gave the company an “overweight” rating in a research report on Friday, March 6th. Weiss Ratings raised LifeStance Health Group from a “sell (d-)” rating to a “hold (c-)” rating in a research report on Friday, February 27th. Finally, BTIG Research raised their target price on LifeStance Health Group from $11.00 to $12.00 and gave the company a “buy” rating in a research report on Friday. Two investment analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, LifeStance Health Group currently has an average rating of “Buy” and a consensus target price of $10.00.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the company. Assetmark Inc. grew its stake in shares of LifeStance Health Group by 17.0% during the 1st quarter. Assetmark Inc. now owns 9,419 shares of the company’s stock worth $60,000 after acquiring an additional 1,367 shares during the period. Park Edge Advisors LLC grew its stake in shares of LifeStance Health Group by 14.4% during the 4th quarter. Park Edge Advisors LLC now owns 11,863 shares of the company’s stock worth $84,000 after acquiring an additional 1,495 shares during the period. California State Teachers Retirement System grew its stake in shares of LifeStance Health Group by 1.6% during the 4th quarter. California State Teachers Retirement System now owns 125,682 shares of the company’s stock worth $885,000 after acquiring an additional 1,966 shares during the period. Vident Advisory LLC grew its stake in shares of LifeStance Health Group by 12.7% during the 2nd quarter. Vident Advisory LLC now owns 21,732 shares of the company’s stock worth $112,000 after acquiring an additional 2,447 shares during the period. Finally, Xponance LLC grew its stake in shares of LifeStance Health Group by 26.4% during the 4th quarter. Xponance LLC now owns 13,144 shares of the company’s stock worth $93,000 after acquiring an additional 2,745 shares during the period. Institutional investors own 85.50% of the company’s stock.

LifeStance Health Group Company Profile

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.